Copyright
©2011 Baishideng Publishing Group Co.
World J Cardiol. Dec 26, 2011; 3(12): 383-387
Published online Dec 26, 2011. doi: 10.4330/wjc.v3.i12.383
Published online Dec 26, 2011. doi: 10.4330/wjc.v3.i12.383
Western Europe | Eastern Europe and Russia |
Andorra | Albania |
Austria | Armenia |
Belgium | Azerbaijan |
Cyprus | Bosnia-Herzegovina |
Denmark | Bulgaria |
Finland | Croatia |
France | Czech Republic |
Germany | Estonia |
Gibraltar | Hungary |
Great Britain | Latvia |
Greece | Lithuania |
Iceland | Moldova |
Ireland | Montenegro |
Italy | Poland |
Liechtenstein | Republic of Belarus |
Luxembourg | Republic of Georgia |
Malta | Republic of Macedonia |
Monaco | Romania |
Netherlands | Russia |
Norway | Serbia |
Portugal | Slovakia |
San Marino | Slovenia |
Scotland | Ukraine |
Spain | Yugoslavia |
Sweden | |
Switzerland | |
Wales |
- Citation: Jahangir E, Comandé D, Rubinstein A. Adequate antiplatelet regimen in patients on chronic anti-vitamin K treatment undergoing percutaneous coronary intervention. World J Cardiol 2011; 3(12): 383-387
- URL: https://www.wjgnet.com/1949-8462/full/v3/i12/383.htm
- DOI: https://dx.doi.org/10.4330/wjc.v3.i12.383